tiprankstipranks
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT

EyePoint Pharmaceuticals (EYPT) Income Statement

773 Followers

EyePoint Pharmaceuticals Income Statement

Last quarter (Q1 2024), EyePoint Pharmaceuticals's total revenue was $11.68M, an increase of 10.93% from the same quarter last year. In Q1, EyePoint Pharmaceuticals's net income was $-29.28M. See EyePoint Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 39.84M$ 46.02M$ 41.40M$ 36.94M$ 34.44M$ 20.36M
Cost of Revenue
$ 759.00K$ 500.00K--$ 5.82M$ 2.69M
Gross Profit
$ 42.91M$ 46.02M$ 41.40M$ 36.94M$ 28.61M$ 17.68M
Operating Expense
$ 134.95M$ 121.08M$ -141.04M$ 92.22M$ 65.90M$ 65.54M
Operating Income
$ -88.45M$ -75.07M$ -78.94M$ -55.28M$ -37.29M$ -47.86M
Net Non Operating Interest Income Expense
$ -1.25M$ -1.25M$ -3.19M$ -5.50M$ -7.20M$ -5.12M
Other Income Expense
$ -7.30M$ -5.60M$ -572.00K$ -2.36M$ -905.00K$ -3.81M
Pretax Income
$ -79.99M$ -70.71M$ -102.25M$ -58.42M$ -45.39M$ -56.79M
Tax Provision
-$ 83.00K$ -842.00K---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -85.98M$ -61.53M$ -102.25M$ -58.42M$ -45.39M$ -56.79M
Basic EPS
$ -2.05$ -1.82$ -2.74$ -2.03$ -3.54$ -5.40
Diluted EPS
$ -2.05$ -1.82$ -2.74$ -2.03$ -3.54$ -5.40
Basic Average Shares
$ 113.46M$ 38.90M$ 37.32M$ 28.76M$ 12.84M$ 10.43M
Diluted Average Shares
$ 113.46M$ 38.90M$ 37.32M$ 28.76M$ 12.84M$ 10.43M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 135.71M$ 121.58M$ -141.04M$ 92.22M$ 71.73M$ 68.23M
Net Income From Continuing And Discontinued Operation
$ -85.98M$ -70.80M$ -102.25M$ -58.42M$ -45.39M$ -56.79M
Normalized Income
$ -52.33M---$ -44.49M$ -52.98M
Interest Expense
----$ 7.26M$ 6.18M
EBIT
$ -78.75M$ -69.47M$ -99.06M$ -52.92M$ -38.14M$ -50.62M
EBITDA
$ -78.09M$ -69.00M$ -96.57M$ -50.11M$ -35.49M$ -48.01M
Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis